CVS Health Corporation
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Track CVS Health Corporation in real time with a live news feed covering CVS Health Corporation stock news, official press releases, company announcements, and an archive of historical CVS Health Corporation news. ...more
Loading news...
Loading more...
1:00 PM | Thursday | May 14, 2026
Sign in to download news snippet
Our 24/7 Wall St. price target for CVS Health (NYSE:CVS | CVS Price Prediction) is $125.45, pointing to meaningful upside from where shares trade today.
Read full articleNo data available for this time period.
Change the time range to see results.
Our 24/7 Wall St. price target for CVS Health (NYSE:CVS | CVS Price Prediction) is $125.45, pointing to meaningful upside from where shares trade today.
Read full article
A bankruptcy court has approved the sale of CVS Health's underperforming Omnicare long-term care pharmacy network to GenieRx in a deal valued at $250 million.
Read full article
New program helps reduce financial barriers to higher education while building a stronger, more robust pharmacy workforce WOONSOCKET, R.I., May 14, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) and WGU today announced a new online pre-pharmacy degree program designed to help address the national need for pharmacists through flexible, affordable education.
Read full article
A bankruptcy court has approved the sale of CVS Health's underperforming Omnicare long-term care pharmacy network to GenieRx in a deal valued at $250 million.
Read full article
New program helps reduce financial barriers to higher education while building a stronger, more robust pharmacy workforce WOONSOCKET, R.I., May 14, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) and WGU today announced a new online pre-pharmacy degree program designed to help address the national need for pharmacists through flexible, affordable education.
Read full article
In-person and virtual services support chronic disease prevention and long-term metabolic health WOONSOCKET, R.I., May 13, 2026 /PRNewswire/ -- As chronic conditions tied to metabolic health continue to rise across the United States, MinuteClinic®, the medical clinic inside select CVS Pharmacy® (NYSE: CVS) locations, is highlighting its clinically supervised weight-loss program to support earlier intervention and more accessible preventive care.
Read full article
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read full article
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read full article
CVS Health Corporation remains deeply undervalued despite persistent headwinds and an 11-year correction, with intrinsic value estimates well above current prices. Q1 2026 results showed 6.2% revenue growth and a 63.1% EPS increase, prompting management to raise full-year guidance for revenue, cash flow, and earnings. Margins and the medical benefit ratio are showing early signs of recovery, supporting management's and analysts' renewed optimism for double-digit EPS growth.
CVS Health NYSE: CVS raised its full-year 2026 adjusted earnings outlook after reporting stronger first-quarter results, with management citing improved performance at Aetna, continued execution at Caremark and resilient pharmacy operations.
Read full article
The +2.48% YoY payment hike for 2027 Medicare Advantage plans and Aetna's higher star rating support CVS Health's recovery prospects toward 2028 target margins. This is significantly aided by the prior premium re-pricing and the ongoing operational efficiencies, as observed in their FQ1 '26 MBR of 84.6% nearing 2019 levels. Readers must not forget their vertically integrated PBM and pharmacy capabilities, allowing them to drive lower medical costs and improved operational efficiencies.
CVS Health Corporation delivered a strong Q1, with revenues of $100.4bn and adjusted EPS up ~14% to $2.57, surpassing expectations. CVS raised 2026 guidance: revenue to $405bn, adjusted EPS to $7.4, and cash flow from operations to $9.
5bn, reflecting renewed operational momentum. Improvement in the medical benefit ratio to 84.6% and robust health insurance segment profitability signal a turnaround in CVS's core business.
Pre-market futures are up nicely this morning as “Peace in the Middle East” once again grabs headlines. The U.S. has paused its three-day blockade at the Gulf of Oman, allowing for safe passage of commercial ships through the Strait of Hormuz.
Read full article
No data available for this time period.
Change the time range to see results.